NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
DCIT Appeals Against Kalpataru Subsidiary Agile Real Estate for AY 2022-23 and 2023-24
The Deputy Commissioner of Income Tax (DCIT) has filed appeals with the Income Tax Appellate Tribunal (ITAT) against Kalpataru's subsidiary, Agile Real Estate Pvt Ltd. This follows a previous ruling by the CIT(A) which had significantly reduced income additions for Assessment Years 2019-20 through 2023-24. The current appeals specifically target the orders for AY 2022-23 and 2023-24. The company plans to contest these appeals and expects a favorable outcome, though the final tax liability remains subject to tribunal proceedings.
முக்கிய அம்சங்கள்
DCIT filed appeals with ITAT against subsidiary Agile Real Estate Pvt Ltd.Appeals concern Assessment Years 2022-23 and 2023-24.CIT(A) had previously reduced income additions for five years (AY 2019-20 to 2023-24).Company received information regarding the appeals on June 12, 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor the ITAT proceedings for any potential tax liability that could impact the consolidated financials of Kalpataru Limited.
Dr. Lal Path Labs Incorporates Dubai Subsidiary with AED 1.91 Crore Investment
Dr. Lal Path Labs has officially incorporated its wholly-owned subsidiary, DR LAL PATHLABS FZCO, in Dubai, UAE, following board approval in April 2026. The company has invested AED 1,91,35,000 (approximately ₹43.5 crore) for a 100% stake in the new entity. This subsidiary is strategically positioned to drive international growth through diagnostic services, potential acquisitions, and joint ventures. The move marks a significant step in the company's geographical diversification strategy beyond the Indian market.
முக்கிய அம்சங்கள்
Incorporated 'DR LAL PATHLABS FZCO' as a Wholly Owned Subsidiary in Dubai on June 12, 2026.Total capital subscription of AED 1,91,35,000 divided into 19,135 shares of AED 1,000 each.The subsidiary will focus on strategic investments in diagnostics and allied activities, including M&A and JVs.Received Certificate of Incorporation/Licence from the Dubai Multi Commodities Centre (DMCC) authority.100% control and shareholding maintained by Dr. Lal PathLabs Limited.
👀 கவனிக்க வேண்டியவை
Investors should monitor the subsidiary's future deployment of capital for acquisitions, as this represents a key international growth lever. The expansion into the UAE market could provide a hedge against domestic competition and diversify revenue streams.
Shalimar Paints FY26 Net Loss Narrows to ₹63.34 Cr; Revenue Declines 5% YoY to ₹569.03 Cr
Shalimar Paints reported a standalone net loss of ₹63.34 crore for FY26, showing improvement from a loss of ₹80.11 crore in FY25. Annual revenue from operations declined by 5% to ₹569.03 crore compared to ₹599.06 crore in the previous fiscal. For the fourth quarter, the net loss narrowed significantly to ₹6.18 crore from ₹26.62 crore in Q3 FY26, although Q4 revenue fell 13.9% YoY to ₹153.06 crore. The company's auditors have provided an unmodified opinion on these results.
முக்கிய அம்சங்கள்
Standalone annual net loss narrowed to ₹63.34 crore in FY26 from ₹80.11 crore in FY25.Full-year revenue from operations decreased by 5% YoY to ₹569.03 crore.Q4 FY26 revenue stood at ₹153.06 crore, a sequential recovery from ₹130.40 crore in Q3.Total expenses for the year were reduced to ₹634.63 crore from ₹689.03 crore in the previous year.Loss per share (Basic) improved to ₹(7.57) for FY26 compared to ₹(10.23) in FY25.
👀 கவனிக்க வேண்டியவை
Investors should note the positive trend in narrowing losses and cost reduction, but the decline in annual revenue remains a concern. Monitor the company's strategy for top-line growth and market share recovery in the competitive paint industry before making new commitments.
CARE Reaffirms Shalimar Paints' Rating at 'BB+' with Negative Outlook Amid FY26 Losses
CARE Ratings has reaffirmed Shalimar Paints' long-term rating at 'CARE BB+' with a 'Negative' outlook, reflecting sustained operational losses and stretched liquidity. The company reported a net loss of ₹63.34 crore in FY26 on a reduced revenue of ₹569.03 crore, down from ₹599.25 crore in FY25. While the capital structure remains satisfactory with a gearing of 0.76x, debt coverage is poor, and the company faces ₹18.30 crore in repayments for FY27 against a cash balance of only ₹7.24 crore. The rating is primarily supported by the strong parentage of the Hella group, which has infused significant equity to support operations.
முக்கிய அம்சங்கள்
CARE reaffirmed the long-term rating at 'BB+' but maintained a 'Negative' outlook due to expected continued losses.Revenue declined to ₹569.03 crore in FY26 from ₹599.25 crore in FY25 as the company exited low-margin products.Liquidity is stretched with free cash of ₹7.24 crore against upcoming debt repayments of ₹18.30 crore in FY27.Promoter Hella and group companies have demonstrated strong support, infusing over ₹400 crore in recent years.Operating losses narrowed to ₹20.81 crore in FY26 from ₹56.48 crore in FY25, showing some progress in cost optimization.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious due to the 'Negative' outlook and liquidity crunch, monitoring the company's ability to turn profitable through its cost-optimization strategy. The primary safety net remains the promoter's (Hella) willingness to continue funding the cash burn.
Kalpataru Limited Withdraws Demerger Scheme for Project Magnus from Subsidiary
Kalpataru Limited has officially withdrawn its Scheme of Arrangement for the demerger of 'Project Magnus' from its wholly-owned subsidiary, Kalpataru Properties Limited. The scheme was originally approved by the Board on January 22, 2024, and filed with the NCLT on September 30, 2024. The Executive Committee decided on June 2, 2026, that the benefits previously envisaged from this restructuring are no longer relevant. The company has clarified that this withdrawal will have no financial impact on either the parent company or the subsidiary.
முக்கிய அம்சங்கள்
Withdrawal of demerger scheme for Project Magnus located in Bandra East, Mumbai.The original scheme was approved on January 22, 2024, with an appointed date of April 1, 2024.The withdrawal was approved by the Executive Committee on June 2, 2026, after determining the scheme's benefits were no longer relevant.Management confirms that the withdrawal has zero financial impact on Kalpataru Limited or Kalpataru Properties Limited.The scheme had been pending with the Hon’ble National Company Law Tribunal (NCLT) since September 2024.
👀 கவனிக்க வேண்டியவை
Investors should view this as a reversal of an internal corporate restructuring plan with no immediate financial consequences. No action is required, though shareholders may monitor future updates regarding the development status of the Bandra East project.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Shalimar Paints CFO Sachin Naik Resigns Effective May 30, 2026
Mr. Sachin Naik has resigned from his position as the Chief Financial Officer (CFO) and Key Managerial Personnel of Shalimar Paints Limited. The resignation is effective from the close of business hours on May 30, 2026. The company stated the reason for his departure is to pursue better career opportunities and professional growth prospects. No immediate successor was announced in the filing.
முக்கிய அம்சங்கள்
Mr. Sachin Naik resigned as Chief Financial Officer (CFO) effective May 30, 2026.The resignation is categorized as a change in Key Managerial Personnel (KMP) under SEBI regulations.The stated reason for resignation is better career opportunities and professional growth.The disclosure was filed in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's upcoming announcements for the appointment of a new CFO to ensure leadership continuity and stability in financial management.
Shalimar Paints Reports First Positive EBITDA Since Acquisition in FY26 Results
Shalimar Paints has achieved a significant operational milestone by reporting positive EBITDA for the full year FY 2025-26, the first since its acquisition by Hella Infra Market Limited. The company successfully implemented cost rationalization measures, specifically reducing employee and manufacturing expenses to improve operating leverage. A strategic shift towards premiumization, particularly in high-margin emulsion products, has enhanced the overall margin profile. Despite industry-wide pricing pressures and volatile demand, the management indicates a successful business turnaround and a strengthened foundation for sustainable growth.
முக்கிய அம்சங்கள்
Delivered positive EBITDA for the first time since the majority stake acquisition by Hella Infra Market Limited.Executed focused cost rationalization leading to significant reductions in employee, manufacturing, and operating expenses.Improved product mix through premiumization and increased saliency of high-margin emulsion products.Statutory auditors Walker Chandiok & Co., LLP issued an unmodified opinion on the audited financial results.Strengthened business fundamentals and operational efficiencies despite persistent sector-wide headwinds.
👀 கவனிக்க வேண்டியவை
Investors should view the positive EBITDA as a critical turnaround signal and monitor if this leads to consistent net profitability. Watch for the company's ability to maintain market share against larger competitors while sustaining these improved margins.
Alpa Laboratories FY26 Consolidated Net Profit Declines 23% to ₹15.01 Crore
Alpa Laboratories Limited reported a decline in its annual financial performance for the year ended March 31, 2026. Consolidated total income fell to ₹121.57 crore from ₹135.80 crore in the previous fiscal year, representing a 10.5% decrease. Net profit for the year dropped by approximately 23% to ₹15.01 crore compared to ₹19.50 crore in FY25. However, the company showed signs of recovery in the final quarter, turning a standalone profit of ₹1.36 crore against a loss of ₹1.95 crore in the same period last year.
முக்கிய அம்சங்கள்
Consolidated annual revenue from operations decreased to ₹105.81 crore from ₹112.45 crore in FY25.Full-year consolidated net profit stood at ₹15.01 crore, down from ₹19.50 crore in the previous year.Consolidated Earnings Per Share (EPS) declined to ₹7.13 from ₹9.27 year-on-year.Standalone Q4 FY26 net profit improved to ₹1.36 crore compared to a net loss of ₹1.95 crore in Q4 FY25.The board appointed M/s S. S. Gandhi & Associates as Internal Auditors and M/s Sudeep Saxena & Associates as Cost Auditors for FY 2026-27.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's declining revenue trend and pressure on annual margins, despite the quarterly turnaround. The stock may face short-term pressure due to the significant year-on-year drop in profitability.
Kalpataru Signs ₹1,250 Cr GDV Cluster Redevelopment Project in Kandivali East
Kalpataru Limited has secured a major cluster redevelopment project in Ashok Nagar, Kandivali East, involving five adjacent societies. The project spans 2.8 acres and is estimated to have a Gross Development Value (GDV) of approximately ₹1,250 crore. It features a free sale potential of 0.37 million square feet (msf) of carpet area and will include both residential and high-street retail components. This move follows a ₹1,400 crore project announcement in Andheri East, signaling aggressive growth in the high-margin Mumbai redevelopment market.
முக்கிய அம்சங்கள்
Estimated Gross Development Value (GDV) of approximately ₹1,250 croreProject covers ~2.8 acres with a free sale potential of ~0.37 msf carpet areaInvolves the cluster redevelopment of five societies in the Ashokgram ClusterStrengthens presence in Kandivali East where the company has already delivered 6 projectsFollows a significant ₹1,400 crore redevelopment project announced in March 2026
👀 கவனிக்க வேண்டியவை
Investors should look favorably on this addition to the project pipeline as it provides strong revenue visibility and leverages Kalpataru's expertise in the Mumbai micro-market. Monitor execution progress and the impact on the company's debt-to-equity ratio as these large-scale projects move into the construction phase.
Kalpataru Ltd FY26: Record Pre-sales of ₹5,280 Cr and 34% Collection Growth
Kalpataru Limited reported a landmark FY26, achieving its highest-ever annual pre-sales of ₹5,280 crores and collections of ₹4,960 crores. The company successfully transitioned to a high-realization phase, delivering 5.15 million square feet in FY26 and targeting 5.5 million square feet for FY27. Financial performance was bolstered by a 54% revenue growth to ₹3,436 crores, while debt optimization efforts reduced interest costs by 120 basis points. Management maintains a strong launch pipeline of ₹7,800 crores for the upcoming fiscal year to sustain momentum.
முக்கிய அம்சங்கள்
Achieved record FY26 pre-sales of ₹5,280 crores (up 17% YoY) and collections of ₹4,960 crores (up 34% YoY).Revenue surged 54% to ₹3,436 crores in FY26, with Q4 alone contributing ₹1,694 crores due to project handovers.Refinanced ₹3,500 crores of debt, resulting in a 120 bps reduction in blended cost and ₹125 crores in annual savings.Planned FY27 launch pipeline of 5 million sq. ft. with an estimated Gross Development Value (GDV) of ₹7,800 crores.Secured a new redevelopment project in Andheri West with an estimated GDV of ₹1,400 crores.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to deleverage as it enters a high-cash-flow realization phase from project completions. The strong launch pipeline and debt cost optimization provide a positive outlook for margin expansion in FY27.
Kalpataru Ltd Approves Composite Scheme of Arrangement to Simplify Group Structure
Kalpataru Limited has approved a composite scheme involving the demerger of the 'Korum Mall' business and the amalgamation of five subsidiaries into the parent entity. The restructuring includes the merger of KRVPL, ARPL, KRPL, ADPL, and AHPL into Kalpataru Limited to streamline operations and reduce regulatory compliance costs. As the merging entities are wholly-owned or step-down subsidiaries, there will be no change in the shareholding pattern of the listed company. The parent company, Kalpataru Limited, reported a net worth of INR 41,003 million as of December 31, 2025.
முக்கிய அம்சங்கள்
Amalgamation of 5 subsidiaries into the listed entity Kalpataru Limited to rationalize group structure.Demerger of 'Korum Mall' business into Kalpataru Properties (Thane) Private Limited for focused management.Kalpataru Limited's standalone net worth stands at INR 41,003 million as of December 2025.Zero change in the shareholding pattern of the listed entity post-scheme implementation.The appointed date for the scheme is April 1, 2026, pending NCLT and regulatory approvals.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive structural cleanup that will likely reduce administrative overhead and improve operational efficiency. Since there is no equity dilution, the focus remains on the consolidated growth of the real estate and mall business verticals.
Kalpataru Ltd FY26 Revenue Surges 55% to ₹3,436 Cr; Net Debt Reduced by ₹1,204 Cr
Kalpataru Limited reported a strong financial performance for FY26, with revenue growing 55% YoY to ₹3,436 crore and PAT increasing to ₹80 crore. Operational momentum remained robust as pre-sales reached ₹5,280 crore, driven by a 20% rise in average realizations to ₹16,719 per sq. ft. A key highlight is the significant deleveraging, with net debt falling by ₹1,204 crore and the debt-to-equity ratio improving from 3.8x to 2.0x. The company maintains a strong launch pipeline of 4.92 msf for FY27 with an estimated GDV of ₹7,770 crore.
முக்கிய அம்சங்கள்
FY26 Pre-sales grew 17% YoY to ₹5,280 crore, while collections rose 34% to ₹4,960 crore.Net Debt significantly reduced to ₹8,106 crore from ₹9,310 crore in the previous year, improving D/E ratio to 2.0x.Consolidated Revenue from operations jumped 55% YoY to ₹3,436 crore in FY26.Achieved occupation certificates for 5.15 msf in FY26, a 1.8x increase over the previous financial year.Planned FY27 launches include 6 projects with an estimated Gross Development Value (GDV) of ₹7,770 crore.
👀 கவனிக்க வேண்டியவை
The company shows strong fundamental improvement through aggressive debt reduction and healthy pre-sales growth. Investors should monitor the execution of the FY27 launch pipeline and the impact of Project Completion Method (PCM) accounting on future earnings volatility.
Kalpataru Reports Record FY26 Pre-sales of ₹5,280 Cr; Net Debt/Equity Drops to 2.0x
Kalpataru Limited reported its highest-ever operational performance for FY26, with pre-sales reaching ₹5,280 crore, a 17% YoY increase. The company saw a significant surge in collections, which grew 34% YoY to ₹4,960 crore for the full year. Q4 FY26 revenue jumped 184% YoY to ₹1,694 crore, driven by project completions and the receipt of Occupation Certificates for several towers. Notably, the Net Debt/Equity ratio improved substantially from 3.8x to 2.0x, reflecting disciplined capital allocation and debt reduction.
முக்கிய அம்சங்கள்
Highest-ever annual pre-sales of ₹5,280 crore (+17% YoY) and collections of ₹4,960 crore (+34% YoY)Q4 FY26 Revenue surged 184% YoY to ₹1,694 crore with a PAT of ₹194 croreAverage sale realization for FY26 increased by 20% YoY to ₹16,719 per sq.ft.Significant deleveraging with Net Debt/Equity ratio dropping from 3.8x to 2.0xReceived Occupation Certificates for ~1.37 msf in Q4, triggering revenue recognition under the PCM method
👀 கவனிக்க வேண்டியவை
Investors should view the strong operational momentum and significant deleveraging as positive signs of financial health. Monitor the execution of the upcoming FY27 launch pipeline to ensure sustained pre-sales growth.
Kalpataru Limited Reports FY26 Net Loss of ₹16.23 Cr as Revenue Declines 26% YoY
Kalpataru Limited reported a weak performance for the financial year ended March 31, 2026, swinging to a standalone net loss of ₹16.23 crore compared to a profit of ₹23.25 crore in the previous year. Revenue from operations dropped significantly by 25.8% to ₹209.80 crore. The fourth quarter also remained under pressure with a net loss of ₹1.19 crore against a profit of ₹16.27 crore in the year-ago period. Total income for the full year saw a sharp decline of 30.6% to ₹372.21 crore, primarily driven by lower operational revenue and other income.
முக்கிய அம்சங்கள்
Standalone revenue from operations fell 25.8% YoY to ₹209.80 crore in FY26Company reported a net loss of ₹16.23 crore for FY26 against a profit of ₹23.25 crore in FY25Total expenses for the year stood at ₹398.63 crore, exceeding the total income of ₹372.21 croreFinance costs remained high at ₹184.49 crore for the full year, significantly impacting the bottom lineEarnings Per Share (EPS) turned negative at -₹0.82 for FY26 compared to ₹1.66 in the previous year
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company has transitioned to a loss-making status amid declining revenues and high finance costs. It is advisable to monitor management's strategy for debt reduction and revenue growth before making new commitments.
Shalimar Paints Re-appoints Atul Desai for 3 Years; Appoints Abhijeet Jhawar to Board
Shalimar Paints has approved the re-appointment of Mr. Atul Rasiklal Desai as an Independent Director for a second three-year term, effective from June 28, 2026, to June 27, 2029. Additionally, the company appointed Mr. Abhijeet Jhawar, the current Chief Marketing Officer of Infra.Market, as an Additional Non-Executive Director effective May 12, 2026. Both appointees bring significant industry experience, with Mr. Desai having over 35 years in building materials and Mr. Jhawar possessing 25 years of expertise across FMCG and infrastructure. These moves are aimed at strengthening the board's strategic depth and alignment with key stakeholders.
முக்கிய அம்சங்கள்
Mr. Atul Desai re-appointed as Independent Director for a second 3-year term starting June 2026.Mr. Abhijeet Jhawar appointed as Additional Non-Executive Director effective May 12, 2026.Mr. Desai brings 35+ years of experience from leadership roles at Prism Johnson and Ambuja Cements.Mr. Jhawar brings 25+ years of experience and currently serves as CMO at Infra.Market.The appointments are subject to the approval of company members.
👀 கவனிக்க வேண்டியவை
Investors should view these appointments as a positive step toward strengthening corporate governance and strategic synergy with Infra.Market. Monitor how these leadership changes impact the company's distribution and marketing strategies in the coming quarters.
Dr. Lal PathLabs Q4 FY26 Revenue Up 16.6% to ₹703 Cr; FY26 Dividend at ₹20.5 Per Share
Dr. Lal PathLabs reported a robust Q4 FY26 with revenue growing 16.6% YoY to ₹703 crore, primarily driven by a 12.9% increase in sample volumes. For the full year FY26, revenue reached ₹2,763 crore with an adjusted EBITDA margin of 28.3% after excluding one-time labor code costs. The company expanded its network by adding 14 labs and over 1,100 collection centers during the year. Management has guided for early to mid-teens revenue growth in FY27 while maintaining EBITDA margins in the 27-28% range.
முக்கிய அம்சங்கள்
Q4 FY26 revenue grew 16.6% YoY to ₹703 crore, while full-year FY26 revenue rose 12.2% to ₹2,763 crore.Sample volume growth stood at 12.9% for Q4 and 10.4% for the full year, indicating strong operational momentum.Adjusted FY26 EBITDA margin was 28.3% excluding a ₹30 crore one-time labor code cost impact.Total dividend for FY26 declared at ₹20.5 per share, reflecting a 280% payout after the 1:1 bonus issue.Net cash and cash equivalents remained strong at ₹1,526 crore, providing liquidity for future M&A and expansion.
👀 கவனிக்க வேண்டியவை
Investors should take note of the strong volume-led growth and the company's successful expansion into high-end specialized testing and premium wellness. The stock remains a solid long-term play in the organized diagnostic sector with healthy cash reserves for inorganic growth.
Dr. Lal PathLabs Completes 100% Acquisition of Shahbazkers Diagnostic Centre
Dr. Lal PathLabs has officially completed the acquisition of a 100% stake in Shahbazkers Diagnostic Centre Private Limited (SDCPL) on May 1, 2026. Following the execution of the Share Purchase Agreement, SDCPL has now become a wholly-owned subsidiary of the company. This acquisition is part of the company's strategy to expand its footprint in the diagnostic services market. The financial details were previously disclosed in an intimation dated April 30, 2026.
முக்கிய அம்சங்கள்
Completed 100% stake acquisition in Shahbazkers Diagnostic Centre Private Limited (SDCPL)SDCPL has officially become a wholly-owned subsidiary of Dr. Lal PathLabs as of May 1, 2026The transaction was finalized in accordance with the Share Purchase Agreement termsMove aligns with the company's inorganic growth strategy to strengthen market presence
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration of SDCPL and its contribution to the company's consolidated revenue and margins in the coming quarters. This expansion reinforces the company's dominant position in the diagnostic sector.
Kalpataru Ltd Issues Corporate Guarantees Worth ₹790 Crore for Subsidiaries
Kalpataru Limited has issued corporate guarantees totaling ₹790 crore in favor of ICICI Bank to secure Rupee Term Loans for two of its subsidiaries. The guarantees support a ₹400 crore loan for Agile Real Estate Private Limited and a ₹390 crore loan for Agile Real Estate Dev Private Limited. Both facilities have a tenure of up to 60 months, and the guarantees will be co-terminus with the loans. While this increases the parent company's contingent liabilities, it is a standard practice to facilitate funding for subsidiary-level real estate projects.
முக்கிய அம்சங்கள்
Total corporate guarantee amount issued is ₹790 crore to ICICI Bank Limited.₹400 crore guarantee provided for subsidiary Agile Real Estate Private Limited.₹390 crore guarantee provided for subsidiary Agile Real Estate Dev Private Limited.The Rupee Term Loans secured by these guarantees have a maximum tenor of 60 months.The guarantees represent a contingent liability for Kalpataru Limited with no immediate cash outflow.
👀 கவனிக்க வேண்டியவை
Investors should monitor the consolidated debt levels and the execution progress of projects under these subsidiaries to assess the risk of guarantee invocation. No immediate action is required as this is a standard financial support move for a real estate parent company.
Dr. Lal PathLabs Q4 Revenue Jumps 16.6% to ₹703 Cr; FY26 Normalized PAT Up 17.9%
Dr. Lal PathLabs reported its highest quarterly revenue growth in 16 quarters, with Q4 FY26 revenue rising 16.6% YoY to ₹703 crore. For the full year FY26, normalized PAT grew by 17.9% to ₹532 crore, supported by a 12.2% increase in total revenue. The company demonstrated strong volume momentum with sample counts increasing by 12.9% in Q4, while maintaining a robust ROCE of 44% excluding cash. Strategic expansion continued with the addition of 14 labs and over 1,100 collection centers during the fiscal year.
முக்கிய அம்சங்கள்
Q4 FY26 revenue grew 16.6% YoY to ₹703 crore, marking the highest growth in 16 quarters.Full-year FY26 normalized PAT increased by 17.9% to ₹532 crore with a stable 28.3% EBITDA margin.Sample volumes grew 12.9% in Q4 FY26, reaching 23.6 million samples for the quarter.SwasthFit (bundled offerings) contribution increased to 28% of revenue in Q4 FY26 compared to 26% last year.Cash and cash equivalents strengthened to ₹1,526 crore as of March 31, 2026.
👀 கவனிக்க வேண்டியவை
Investors should focus on the accelerating volume growth and successful penetration into Tier 3 and 4 markets. The strong cash position and stable margins provide a solid foundation for future organic and inorganic growth in the diagnostic space.
Dr. Lal PathLabs Recommends ₹4 Dividend, Acquires SDCPL, and Expands to Dubai
Dr. Lal PathLabs has announced its FY26 results along with a final dividend of ₹4 per share (40% of face value). The company is significantly expanding its footprint by acquiring 100% of Shahbazkers Diagnostic Centre and establishing a new wholly-owned subsidiary in Dubai, UAE. Leadership stability is ensured with the re-appointment of Executive Chairman Dr. Arvind Lal for another five-year term. Additionally, the company increased its paid-up capital through the allotment of 82,750 equity shares under its ESOP scheme.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹4 per equity share for the financial year ended March 31, 2026.Approved the 100% acquisition of Shahbazkers Diagnostic Centre Private Limited (SDCPL).Announced international expansion through the incorporation of Dr. Lal PathLabs FZCO in Dubai, UAE.Re-appointed (Hony) Brig. Dr. Arvind Lal as Executive Chairman for five years starting April 1, 2027.Allotted 82,750 equity shares under ESOP 2022, bringing total paid-up equity capital to ₹167.64 crore.
👀 கவனிக்க வேண்டியவை
Investors should take note of the June 26, 2026, record date for the ₹4 dividend and the company's aggressive inorganic growth strategy. The entry into the Dubai market and domestic acquisitions suggest a strong growth trajectory for the coming years.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
